苯扎贝特对兔动脉粥样硬化单核细胞趋化因子的影响

被引:2
作者
李彦琦
董秋立
刘海涛
何敬堂
郭水英
机构
[1] 华北石油总医院干部保健科
关键词
动脉粥样硬化; 趋化因子,单核细胞; 苯扎贝特; 兔;
D O I
暂无
中图分类号
R965 [实验药理学];
学科分类号
100602 ; 100706 ;
摘要
目的探讨苯扎贝特对兔动脉粥样硬化(AS)时单核细胞趋化因子(MCP-1)的影响。方法 24只新西兰大白兔随机分为高脂组、苯扎贝特组和正常对照组,每组8只。对照组饲以常规颗粒饲料,高脂组饲以高胆固醇饲料(1%胆固醇+5%猪油的颗粒饲料),苯扎贝特组饲以高胆固醇饲料加苯扎贝特[5mg/(kg·d)],共饲养4个月。HE染色检测免胸主动脉AS程度,并用免疫组化检测AS斑块的MCP-1蛋白及RT-PCR检测MCP-1 mRNA的转录水平,同时检测血胆固醇和甘油三酯的浓度。结果与高脂组比较,苯扎贝特显著降低了甘油三酯的浓度[(0.71±0.11)vs(1.72±0.96)mmol/L,P<0.05]。在苯扎贝特组动脉粥样硬化的程度明显减轻,动脉内膜面积减少[(2.92±0.54)vs(4.16±0.98)mm2,P<0.05]。苯扎贝特治疗组斑块内的MCP-1蛋白表达减少[(19.8±2.2)%vs(26.2±3.1)%,P<0.01],RT-PCR结果显示,苯扎贝特组MCP-1 mRNA的水平亦明显减少[(0.61±0.06)vs(1.06±0.06),P<0.05]。结论使用苯扎贝特明显减轻了动脉粥样硬化程度,其中MCP-1基因及蛋白表达的下降具有重要的作用。
引用
收藏
页码:265 / 268
页数:4
相关论文
共 5 条
[1]  
Peroxisome Proliferator–Activated Receptor Ligand Bezafibrate for Prevention of Type 2 Diabetes Mellitus in Patients With Coronary Artery Disease[J] . Alexander Tenenbaum,Michael Motro,Enrique Z. Fisman,Ehud Schwammenthal,Yehuda Adler,Ilan Goldenberg,Jonathan Leor,Valentina Boyko,Lori Mandelzweig,Solomon Behar.Circulation: Journal of the American Heart Association . 2004 (18)
[2]   Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice [J].
Dawson, TC ;
Kuziel, WA ;
Osahar, TA ;
Maeda, N .
ATHEROSCLEROSIS, 1999, 143 (01) :205-211
[3]   Anti-monocyte chemoattractant protein-1 monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries [J].
Furukawa, Y ;
Matsumori, A ;
Ohashi, N ;
Shioi, T ;
Ono, K ;
Harada, A ;
Matsushima, K ;
Sasayama, S .
CIRCULATION RESEARCH, 1999, 84 (03) :306-314
[4]  
Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice[J] . Long Gu,Yoshikatsu Okada,Steven K. Clinton,Craig Gerard,Galina K. Sukhova,Peter Libby,Barrett J. Rollins.Molecular Cell . 1998 (2)
[5]   Effect of bezafibrate treatment over five years on coronary plaques causing 20% to 50% diameter narrowing (The Bezafibrate Coronary Atherosclerosis Intervention Trial [BECAIT]) [J].
Ericsson, CG ;
Nilsson, J ;
Grip, L ;
Svane, B ;
Hamsten, A .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (09) :1125-1129